Patents by Inventor Jinglong Chen
Jinglong Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11959238Abstract: A system for a sandy soil landfill solid waste polluted river channel, includes a ground water interception and diversion system and a river channel ecological remediation system. The ground water interception and diversion system includes a water intake well arranged upstream of ground water in a landfill area, a buffer pool communicated with the water intake well, and a wastewater treatment system communicated with the buffer pool. The water intake well, the buffer pool, and the wastewater treatment system are communicated through a wastewater pipe. An electric wastewater valve and a variable frequency water pump are arranged on the wastewater pipe in sequence. The river channel ecological remediation system includes an impermeable layer arranged at a bottom of a river channel and ecological bank protections arranged on both sides of a river channel slope.Type: GrantFiled: November 24, 2023Date of Patent: April 16, 2024Assignee: Nanjing Institute of Environmental Sciences, MEEInventors: Houhu Zhang, Xiaofei Yan, Jinglong Liu, Lichen Liang, Congcong Sun, Xiang Chen, Cheng Zhang
-
Patent number: 11926549Abstract: The present disclosure discloses a treatment process and treatment system of enhanced up-flow multiphase wastewater oxidation. The treatment process includes the following steps: 1) the wastewater is fed into the up-flow multiphase wastewater oxidation system for oxidation treatment; 2) the wastewater is fed to the solid-liquid separation system for solid-liquid separation, the separated heterogeneous catalytic carrier (5) is fed back to the up-flow multiphase wastewater oxidation system, and the wastewater is fed to the neutralization and degassing system; 3) the wastewater is fed to the neutralization and degassing system to adjust a pH of the wastewater to 5.5-7.5, and then is degassed by stirring; 4) the wastewater is fed to the flocculation and sedimentation system for sludge-water separation, a supernatant is discharged, and an outward harmless treatment is performed after a pressure filtration of a sedimentary iron sludge.Type: GrantFiled: July 4, 2019Date of Patent: March 12, 2024Assignee: Guangxi Bossco Environmental Protection AgencyInventors: Qifeng Yang, HongXiang Zhu, Guoning Chen, Hainong Song, Lihai Lu, Yanding Qin, Xi Liu, Yongli Chen, Hongfei Lin, Qianling Chen, Jinglong Wang
-
Patent number: 11339958Abstract: A lighting apparatus includes a driver, a metal plate, a light source module and a conductor unit. The driver receives an alternating current power source and converts the alternating current power source to a driving current. The metal plate is electrically connected to a ground. The light source module has a substrate and multiple LED modules. The multiple LED modules are mounted on the substrate. The substrate is disposed upon the metal plate. The conductor unit has a first end connected to the substrate of the light source module and a second end connected to the metal plate for removing a parasitic capacitance between the substrate of the light source and the metal plate for preventing a noise occurred when the LED module is turned on and the metal plate is connected to the ground.Type: GrantFiled: February 5, 2021Date of Patent: May 24, 2022Assignee: XIAMEN LEEDARSON LIGHTING CO., LTDInventors: Hemu Ye, Jinglong Chen, Yankun Li, Qiyi Jiang
-
Publication number: 20210270451Abstract: A lighting apparatus includes a driver, a metal plate, a light source module and a conductor unit. The driver receives an alternating current power source and converts the alternating current power source to a driving current. The metal plate is electrically connected to a ground. The light source module has a substrate and multiple LED modules. The multiple LED modules are mounted on the substrate. The substrate is disposed upon the metal plate. The conductor unit has a first end connected to the substrate of the light source module and a second end connected to the metal plate for removing a parasitic capacitance between the substrate of the light source and the metal plate for preventing a noise occurred when the LED module is turned on and the metal plate is connected to the ground.Type: ApplicationFiled: February 5, 2021Publication date: September 2, 2021Inventors: Hemu Ye, Jinglong Chen, Yankun Li, Qiyi Jiang
-
Patent number: 10314802Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: GrantFiled: August 1, 2017Date of Patent: June 11, 2019Assignee: Signum Biosciences, Inc.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Publication number: 20170368011Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: ApplicationFiled: August 1, 2017Publication date: December 28, 2017Applicant: SIGNUM BIOSCIENCES, INC.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Patent number: 9744147Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: GrantFiled: May 10, 2016Date of Patent: August 29, 2017Assignee: Signum Biosciences, Inc.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Publication number: 20170072184Abstract: Provided is a wearable smart drug-delivery system, including a power supply, a drug sac structure, a repository, and an electrode structure. The wearable smart drug-delivery system can accurately and precisely control the dosage and delivery time of an ionized pharmaceutical agent, reducing and preventing uncontrolled doses of transdermally delivered drugs. A plurality of drugs may be stored in one repository or a plurality of repositories in the wearable smart drug-delivery system, and may, at the same time or at different times, be delivered into the body by means of one or a plurality of power supplies; furthermore, storing the plurality of drugs in the plurality of repositories can prevent reactions and interferences between drugs.Type: ApplicationFiled: October 22, 2015Publication date: March 16, 2017Applicant: XIAMEN MICROTECH BIOSCIENCES CO., LTDInventors: Joseph Zhili Huang, Jason Jinglong CHEN
-
Publication number: 20160361283Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: ApplicationFiled: May 10, 2016Publication date: December 15, 2016Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Publication number: 20130310559Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: ApplicationFiled: February 6, 2013Publication date: November 21, 2013Applicant: SIGNUM BIOSCIENCES, INC.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Patent number: 8372884Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: GrantFiled: November 12, 2009Date of Patent: February 12, 2013Assignee: Signum Biosciences, Inc.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Publication number: 20100184768Abstract: Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.Type: ApplicationFiled: November 12, 2009Publication date: July 22, 2010Applicant: SIGNUM BIOSCIENCES, INC.Inventors: Jeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
-
Patent number: D998205Type: GrantFiled: January 8, 2022Date of Patent: September 5, 2023Assignee: Shenzhen Haoyue Technology Co., Ltd.Inventor: Jinglong Chen